این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Hematology-Oncology and Stem Cell Research، جلد ۱۵، شماره ۳، صفحات ۱۹۲-۱۹۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Parvovirus 4 in Individuals with Severe Hemophilia A and Matched Control Group
چکیده انگلیسی مقاله Background: Hemophilia is a well-known bleeding disorder with worldwide distribution. Replacement therapy, using plasma-derived or recombinant coagulation factors, comprises a gold standard regimen for the treatment. Regardless of the advancements made in viral inactivation methods in the production of plasma-derived coagulation factors, the possibility of transmission of new viral infections remained as a noticeable concern yet. The aim of the current study was to investigate the status of parvovirus 4 (PARV4) in severe hemophilia A, von Willebrand disease (vWD), and healthy control. Materials and Methods: In the current case-control study, 76 patients with hemophilia and vWD and 60 individuals from their family members entered the study. Nested PCR used to determine the presence of PARV4 in study subjects (76 cases). To characterize the PARV4 genotype, positive samples subjected to sequencing and phylogenetic analysis. Results: PARV4 genome detected in 11 (14.47%) patients with bleeding disorders. Among whom, nine patients (14.75%) were with severe hemophilia A and two (13.33%) patients with vWD. Only five healthy controls (8.33%) were positive for PARV4. All PARV4 sequences were found to be genotype 1. Conclusion: PARV4 infection in patients with hemophilia and vWD was higher than the control group. While detection of PARV4 DNA in patients with bleeding disorders may not necessarily reflect a clinical urgency, future investigations are needed to define the clinical significance of PARV4. It seems the detection of the virus immune signature of PARV4 infection, particularly in the context of acute and persistent infections, needs to focus on cellular and tissue targets.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Sanaz Asiyabi
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran


| Seyed Mahdi Marashi
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran


| Rohollah Vahabpour
Department of Medical Lab Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran


| Ahmad Nejati
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran


| Alireza Azizi-Saraji
Iranian Comprehensive Hemophilia Care Center, Tehran, Iran


| Aliyeh Sadat Mustafa
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran


| Asgar Baghernejad
School of Public Health, Tehran University of Medical Sciences, Tehran, Iran


| zabihollah Shoja
Department of Virology, Pasteur Institute of Iran, Tehran, Iran


| Hassan Mansouritorghabeh
Central Diagnostic Laboratories, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
نشانی اینترنتی https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1299
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات